Please login to the form below
W Communications strengthens management team
Sunil Ramkali and Elisabet Ek join as partners
Swedish B2B W Communication Agency has named Sunil Ramkali and Elisabet Ek as its new partners.
Ramkali has headed W's life science business unit for over three years and has 25 years of experience in various pharma commercial roles, such as global brand manager at AstraZeneca and market access manager and international product manager at ALK.
It is hoped his experience will aid the agency's clients in areas such as brand development, product launches, pricing strategies and sales support.
Ek (pictured) has held the role of account manager at W since 2012 and is responsible for strategic and creative assignments from the agency's international clients.
Ek also joined W from a client-based background, holding previous roles including international marketing communicator at medical technology firm Atos medical and as Nordic marketing communication manager at Gense.
Lisa Henningsson Önnerlid, CEO at W Communication Agency, commented: “We are genuinely happy to welcome Sunil and Elisabet as partners. Each one of these talents has demonstrated an exceptional commitment to our clients and the agency over the years.”
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Takeda and Daiichi Sankyo collaborate to create wearable device
- Scientists discover new approach to treat brain tumours
- New Pfizer initiative, ‘An Accord for a Healthier World’, launched to improve global health equity
- Pfizer/BioNTech COVID-19 vaccine produces strong immune response in children
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- Dermavant’s Vtama receives FDA approval for plaque psoriasis
- Phase 3 trial initiated to evaluate AZ's Saphnelo in lupus nephritis
- Dermavant’s Vtama receives FDA approval for plaque psoriasis
- EORTC and Pierre Fabre launch phase 3 trial for melanoma
- Using ethnography to uncover the authentic patient experience
- 11 London: first UK healthcare agency to be awarded B Corp status
- Improving Drug Access with Data Analytics
No results were found
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- How ‘Greenwashing’ accusations could delay the very changes its supporters demand
- Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
- What does the future hold for clinical trial recruitment?
- The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
- When is an agency not an agency?
- The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
